The double-stranded DNA genome of human hepatitis B virus (HBV) and re
lated hepadnaviruses is reverse transcribed from a pregenomic RNA by a
viral polymerase (Pol) harboring both priming and RNA-and DNA-depende
nt elongation activities, Although hepadnavirus replication occurs ins
ide viral nucleocapsids, or cores, biochemical systems for analyzing t
his reaction are currently limited to unencapsidated Pols expressed in
heterologous systems, Here, we describe cis and trans classes of repl
icative HBV cores, produced in the recombinant baculovirus system via
coexpression of HBV core and Pol proteins from either a single RNA (i.
e,, in cis) or two distinct RNAs (in trans), Upon isolation from insec
t cells, cis and trans cores contained Pol-linked HBV minus-strand DNA
with 5' ends mapping to the authentic elongation origin DR1 and also
plus-strand DNA species, Only trans cores, however, were highly active
for the de novo priming and reverse transcription of authentic HBV mi
nus strands in in vitro endogenous polymerase assays, This reaction st
rictly required HBV Pol but not the epsilon stem-loop element, althoug
h the presence of one epsilon, or better, two epsilon s, enhanced minu
s-strand synthesis up to 10-fold, Compared to unencapsidated Pol enzym
es, encapsidated Pol appeared to be (i) highly processive, able to ext
end minus-strand DNAs of 400 nucleotides from DR1 in vitro, and (ii) m
ore active for HBV plus-strand synthesis. These observations suggest p
ossible contributions to the replication process from the HBV core pro
tein. These novel core reagents should facilitate the analysis of HBV
replication in its natural environment, the interior of the capsid, an
d also fuel the development of new anti-HBV drug screens.